e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Pulmonary hypertension in the clinic
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serial brain natriuretic peptides track change in 6 minute walk distance in pulmonary arterial hypertension
C. Carlin, K. Blyth, L. McLure, R. Spooner, A. Peacock, M. Johnson (Glasgow, United Kingdom)
Source:
Annual Congress 2007 - Pulmonary hypertension in the clinic
Session:
Pulmonary hypertension in the clinic
Session type:
Electronic Poster Discussion
Number:
3286
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Carlin, K. Blyth, L. McLure, R. Spooner, A. Peacock, M. Johnson (Glasgow, United Kingdom). Serial brain natriuretic peptides track change in 6 minute walk distance in pulmonary arterial hypertension. Eur Respir J 2007; 30: Suppl. 51, 3286
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Stroke volume reflects changes in six minute walk test during follow-up in pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Can brain natriuretic peptide (BNP) be a predictor for pulmonary arterial hypertension?
Source: Annual Congress 2007 - Pulmonary hypertension: diagnosis and treatment
Year: 2007
Incapacity to increase pulmonary blood flow determines 6 minutes walking distance in pulmonary hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020
Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004
The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005
Connection of traditional echocardiographic and tissue doppler imaging parameters and brain natriuretic peptide levels in patients with different forms of pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Comparison of pulse oximetry and capillary blood gases pre and post six minute walk tests in healthy volunteers and patients with pulmonary arterial hypertension (PAH)
Source: Eur Respir J 2006; 28: Suppl. 50, 727s
Year: 2006
The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1294-1301
Year: 2010
Cardiac function during exercise in pulmonary arterial hypertension
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
NT-proBNP reflects right ventricular structure and function in pulmonary hypertension
Source: Eur Respir J 2006; 28: 1190-1194
Year: 2006
Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
N-terminal pro-brain natriuretic peptide in patients with acute pulmonary embolism
Source: Eur Respir J 2003 Oct 01;22(4):649-653
Year: 2003
Mean pulmonary artery pressure-heart rate (mPAP-HR) relationship during submaximal supine exercise in idiopathic pulmonary arterial hypertension (iPAH)
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005
Heart rate responses during the 6-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2006; 27: 114-120
Year: 2006
6 minute walk work and other clinical correlates of peak VO2 in pulmonary vascular disease
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension
Source: Eur Respir J 2007; 29: 737-744
Year: 2007
Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept